Loss of Mfn2 in FECD, which is an age-related disorder of corneal endothelium, is consistent with previous reports showing a decline in Mfn2 in accelerated aging of muscle cells29 and in Alzheimer’s disease (AD) models49. This evidence concerns the gene MFN2 and early-onset autosomal dominant Alzheimer disease.